What Korean Biopharma Firms Need To Consider Before Deal Negotiations

Licensing Deals Falling, But Firms Actively Moving

 
• By Jung Won Shin

A report by Korea Bio-Economy Research Center outlines key factors that could help ensure successful licensing deal negotiations for Korean biopharmas.

dealmaking
Bioventure License Deal Performance Increasingly Assessed During IPO Filings • Source: Shutterstock

More from Deals

More from Business